<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; lever</title>
	<atom:link href="http://www.tapanray.in/tag/lever/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Pharma Brand Building: Criticality of Enhancing End-To-End Customer Experience</title>
		<link>http://www.tapanray.in/pharma-brand-building-criticality-of-enhancing-end-to-end-customer-experience/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharma-brand-building-criticality-of-enhancing-end-to-end-customer-experience</link>
		<comments>http://www.tapanray.in/pharma-brand-building-criticality-of-enhancing-end-to-end-customer-experience/#comments</comments>
		<pubDate>Mon, 02 Jul 2018 00:00:44 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[building]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[criticality]]></category>
		<category><![CDATA[customer]]></category>
		<category><![CDATA[end-to-end]]></category>
		<category><![CDATA[enhancing]]></category>
		<category><![CDATA[episodes]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[growth]]></category>
		<category><![CDATA[increase]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[lever]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[primary]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Representatives]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[source]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[touchpoints]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9028</guid>
		<description><![CDATA[In today’s fast-changing world, the types of medicines being developed, the way technology contributes to health, and how the value of health care is calculated, are all undergoing a metamorphosis. A wave of cell and gene therapies are bending the definition &#8230; <a href="http://www.tapanray.in/pharma-brand-building-criticality-of-enhancing-end-to-end-customer-experience/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharma-brand-building-criticality-of-enhancing-end-to-end-customer-experience/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
